VTv Price To Sales Ratio from 2010 to 2024
| VTVT Stock | USD 15.51 0.09 0.58% |
Price To Sales Ratio | First Reported 2010-12-31 | Previous Quarter 29.01 | Current Value 27.56 | Quarterly Volatility 52.40253253 |
Check VTv Therapeutics financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among VTv Therapeutics' main balance sheet or income statement drivers, such as Depreciation And Amortization of 85.5 K, Interest Expense of 12.3 K or Selling General Administrative of 11.5 M, as well as many indicators such as Price To Sales Ratio of 27.56, Dividend Yield of 0.0 or Days Sales Outstanding of 2 K. VTv financial statements analysis is a perfect complement when working with VTv Therapeutics Valuation or Volatility modules.
VTv | Price To Sales Ratio |
Latest VTv Therapeutics' Price To Sales Ratio Growth Pattern
Below is the plot of the Price To Sales Ratio of vTv Therapeutics over the last few years. Price to Sales Ratio is figured by comparing vTv Therapeutics stock price to its revenues. An advantage to using Price to Sales ratio is that it is based on VTv Therapeutics sales, a figure that is much harder to manipulate than other vTv Therapeutics multiples. Because sales tend to be more stable P/S ratio can be a good tool for screening cyclical companies fluctuating earnings patterns. It is a valuation ratio that compares a company's stock price to its revenues, calculated by dividing the company's market cap by its total sales or revenue over a 12-month period. VTv Therapeutics' Price To Sales Ratio historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in VTv Therapeutics' overall financial position and show how it may be relating to other accounts over time.
| View | Last Reported 40.52 X | 10 Years Trend |
|
Price To Sales Ratio |
| Timeline |
VTv Price To Sales Ratio Regression Statistics
| Arithmetic Mean | 62.60 | |
| Geometric Mean | 40.69 | |
| Coefficient Of Variation | 83.70 | |
| Mean Deviation | 41.35 | |
| Median | 58.39 | |
| Standard Deviation | 52.40 | |
| Sample Variance | 2,746 | |
| Range | 198 | |
| R-Value | (0.56) | |
| Mean Square Error | 2,021 | |
| R-Squared | 0.32 | |
| Significance | 0.03 | |
| Slope | (6.59) | |
| Total Sum of Squares | 38,444 |
VTv Price To Sales Ratio History
About VTv Therapeutics Financial Statements
VTv Therapeutics shareholders use historical fundamental indicators, such as Price To Sales Ratio, to determine how well the company is positioned to perform in the future. Although VTv Therapeutics investors may analyze each financial statement separately, they are all interrelated. The changes in VTv Therapeutics' assets and liabilities, for example, are also reflected in the revenues and expenses on on VTv Therapeutics' income statement. Understanding these patterns can help investors time the market effectively. Please read more on our fundamental analysis page.
| Last Reported | Projected for Next Year | ||
| Price To Sales Ratio | 29.01 | 27.56 |
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for VTv Stock Analysis
When running VTv Therapeutics' price analysis, check to measure VTv Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy VTv Therapeutics is operating at the current time. Most of VTv Therapeutics' value examination focuses on studying past and present price action to predict the probability of VTv Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move VTv Therapeutics' price. Additionally, you may evaluate how the addition of VTv Therapeutics to your portfolios can decrease your overall portfolio volatility.